香港股市 已收市

BBIO Jul 2024 30.000 call

OPR - OPR 延遲價格。貨幣為 USD。
加入追蹤清單
3.2000-1.2000 (-27.27%)
市場開市。 截至 03:59PM EDT。
全螢幕
前收市價4.4000
開市3.5400
買盤2.9500
賣出價3.2000
拍板30.00
到期日2024-07-19
今日波幅2.7900 - 3.5700
合同範圍
成交量2,197
未平倉合約3.16k
  • InvestorPlace

    The 3 Best Biotech Stocks to Buy in June 2024

    The biotech sector, under the life sciences umbrella, exited 2023 with 41 bankruptcies. This was not surprising given the disparity between biotech’s high-capital requirements and rising interest rates set by the Fed. Despite these challenges, some of the best biotech stocks show promise and resilience in a volatile market environment. At the same time, smaller biotech deals became prevalent, accounting for $17 billion during 2023, per JP Morgan data. Another noticeable trend was the uptick in m

  • Investor's Business Daily

    BridgeBio Stock Gives Up Gains On Comparisons To BioMarin Drug

    BridgeBio stock gave up gains midday Tuesday after releasing a Phase 2 study on a growth disorder treatment.

  • InvestorPlace

    7 Biotech Stocks to Put on Your Breakthrough Radar

    For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let’s get some of the bad stuff out of the way first. Biotech stocks – even the established players – can be volatile. A miss in the clinical process to commercialize a therapeutic could lead to significant losses. And there’s really no way of reliably forecasting such outcomes. Plus, the sector isn’t always known for delivering predictable financi